Bulk Orders 20+ vials
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
Growth Hormone & Growth Factor Research
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). Labs study it in growth hormone and IGF-1 pathway research. It is sold for lab research only.
Bundle & saveApplies to every size
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkSelect a product option
Choose a size to check its batch and certificate. Published reports remain available below; check the lot before using a report.
Verified test results
Each batch is analyzed by an independent third-party laboratory before release. The lots below were tested by Chromate and ILS Laboratories. Below is the report for lot TSM04, summarized from the certificate the lab published.
Every lot we have published for this compound, grouped by the lab that tested it, newest first. Open any certificate below, exactly as the lab released it.
Labeled10mg
IdentityConfirmed
TestedNov 11, 2026
View certificate →On recordLabeled20mg
Measured21.46mg
IdentityConfirmed
TestedOct 16, 2026
View certificate →On recordLabeled10mg
IdentityConfirmed
Measured10.67mg
TestedSep 4, 2026
View certificate →On recordLabeled5mg
IdentityConfirmed
Measured5.33mg
TestedAug 24, 2026
View certificate →On recordLabeled10mg
IdentityConfirmed
Measured10.43mg
TestedJul 26, 2026
View certificate →Side by side
Technical specifications
Peer-reviewed literature
Every reference below is a published, peer-reviewed record, linked to its PubMed entry. Provided for educational reference only - not product claims.
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Lyophilized research material
A GHRH analog that stimulates the growth-hormone signaling system through the pituitary GHRH receptor.
Tesamorelin is a modified growth hormone-releasing hormone peptide. It is not growth hormone itself. The vial amount describes supplied material, not an administration recommendation.
A controlled physiological investigation measured GH pulsatility and IGF-1 following tesamorelin exposure in men. It supports the endocrine mechanism for the study formulation.
Published findings describe the materials and conditions in the cited studies. Receptor or cell-pathway evidence does not establish safety or efficacy of this finished research product. Match the supplied identity and format to the current label and batch documentation.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). Labs study it in growth hormone and IGF-1 pathway research. It is sold for lab research only.
Each batch goes through our own quality checks and third-party lab testing. Our in-house team then packs and ships every order.
Tesamorelin is a chain of 44 amino acids. It keeps the full sequence of human GHRH(1-44), with a C-terminal amide. It adds a trans-3-hexenoyl group to the first amino acid, a tyrosine. It was developed under the code TH9507.
In early lab work, that added group made the peptide resistant to the enzyme dipeptidyl aminopeptidase-IV (DPP-IV). It also slowed the peptide's breakdown in plasma in vitro (Ferdinandi et al., 2007).
The same report covers daily repeat studies in pigs, rats and dogs. In those animals, it raised plasma growth hormone and IGF-1 (Ferdinandi et al., 2007).
| Class | stabilized GHRH analog |
|---|---|
| Length | 44 amino acids, with a C-terminal amide |
| Molecular formula | C221H366N72O67S |
| Molecular weight | 5135.86 g/mol |
| Form | powder, lyophilized in the USA |
Tesamorelin is studied as a GHRH analog. That makes it relevant to research on pituitary signaling, growth hormone release and IGF-1 activity. Labs also use it in models of endocrine and metabolic regulation.
Many sellers say their products are "third-party tested." Testing only counts when the labs can be trusted and someone checks the data. We vetted each lab partner ourselves before we started work with them.
Testing is one part of a wider quality system. That system covers holding suppliers to account, batch review, internal QA, storage and in-house shipping.
Tesamorelin research guide · Tesamorelin research guide
Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.
Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.
The listed milligrams refer to material per vial, not concentration or administration instructions. A prepared solution has its own concentration and stability requirements. Verify the exact selected option and shipping lot.
Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.
Human growth hormone-releasing hormone (GHRH). Tesamorelin keeps GHRH's full 44-amino-acid sequence with its C-terminal amide and adds a trans-3-hexenoyl group to the first tyrosine; in preclinical work, that change made it resistant to dipeptidyl aminopeptidase-IV and slowed its in vitro breakdown in rat, dog and human plasma. It was developed under the code TH9507.
All three are analogs of growth hormone-releasing hormone (GHRH): tesamorelin keeps all 44 residues, while sermorelin is GRF(1-29), the first 29, and CJC-1295 is a 29-residue analog with four substitutions whose DAC form adds an albumin-binding lysine. Tesamorelin's own change is a trans-3-hexenoyl group on its first tyrosine.
Yes. The 2026 World Anti-Doping Agency Prohibited List names tesamorelin among growth hormone-releasing hormone (GHRH) analogues under S2.2.4, growth hormone releasing factors, in class S2, which is prohibited at all times. A 2023 doping-control method validated for urine screening covers it.
Disguised Alpha lists tesamorelin here in 5MG, 10MG and 20MG vials, with stock shown by size, for laboratory research only, as powder lyophilized in the USA. Each published lot's certificate of analysis appears on this page under the lab that tested it, ILS Laboratories or Chromate. Orders ship from the US West Coast, with tracked delivery on every order.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.
We share visit and purchase data with advertising partners to measure and show ads. Some US state laws, including California's, call that a sale or sharing of personal information. You can turn it off for this browser.
Ad sharing is on in this browser.
Saved in this browser only. For your account or other devices, email support@disguisedalpha.com. Privacy Policy